Simms Research

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Triple GIP/GLP-1/glucagon receptor co-agonist in clinical trials for obesity and metabolic disease.

Synthetic pentadecapeptide derived from gastric juice studied for tendon, ligament, and gut healing.

Synthetic pentadecapeptide derived from gastric juice studied for tendon, ligament, and gut healing.

Selective GH secretagogue and ghrelin mimetic studied for growth hormone release with minimal side effects.

Neuropeptide studied for promoting slow-wave sleep, stress modulation, and anti-oxidative effects.

Tetrapeptide derived from the pineal gland studied for telomere elongation and anti-aging effects.

Copper-bound tripeptide studied for skin rejuvenation, hair growth, and wound healing.

Copper-bound tripeptide studied for skin rejuvenation, hair growth, and wound healing.

Selective GH secretagogue and ghrelin mimetic studied for growth hormone release with minimal side effects.

Tripeptide derived from alpha-MSH studied for gut inflammation and wound healing.

α-MSH analogue and melanocortin receptor agonist studied for skin tanning and photoprotection.

Non-selective melanocortin receptor agonist studied for tanning, libido, and appetite suppression.

Mitochondria-encoded peptide studied for metabolic regulation, insulin sensitivity, and exercise mimicry.

Essential coenzyme studied for cellular energy metabolism, sirtuin activation, and longevity pathways.

Essential coenzyme studied for cellular energy metabolism, sirtuin activation, and longevity pathways.

Synthetic tuftsin analogue studied for anxiolytic, nootropic, and immunomodulatory effects.

ACTH-derived heptapeptide studied for neuroprotection, cognitive enhancement, and BDNF upregulation.

Truncated analogue of endogenous GHRH studied for stimulating pulsatile GH secretion.

FDA-approved GHRH analogue researched for visceral fat reduction and GH deficiency.

FDA-approved GHRH analogue researched for visceral fat reduction and GH deficiency.

Thymic peptide studied for T-cell maturation, immune modulation, and antiviral activity.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Dual GIP/GLP-1 receptor agonist studied for weight loss and type 2 diabetes management.

Synthetic fragment of Thymosin Beta-4 researched for wound healing, muscle repair, and anti-inflammation.

Mitochondria-targeted tetrapeptide studied for cardioprotection and mitochondrial bioenergetics.

C-terminal fragment of kisspeptin studied for GnRH pulse stimulation and reproductive axis regulation.

Melanocortin receptor agonist (FDA-approved as Vyleesi) studied for sexual dysfunction in men and women.

C-terminal fragment of hGH studied for lipolysis and fat-burning without IGF-1 elevation.